EUVIMEDEUVIMED entdecken
Crossref

Proteome-wide Mendelian randomization identifies therapeutic targets for asthma

Yuhui Yan, Xiaohua Chen

International Journal of Health Sciences · 2026

DOI: 10.25259/ijhs_215_2025 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Health Sciences, 2026. Verfasst von Yuhui Yan und 1 weiteren Autor:innen. Die Arbeit nennt 38 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

Asthma is a prevalent chronic inflammatory disease that involves a complex interaction between various cells of the innate and adaptive immune systems and epithelial cells. Anti-inflammatory therapeutic approaches have proven superior in controlling asthma and reducing exacerbation rates and are receiving increasing attention. The treatment of asthma is a potentially actionable target pending further validation. This study presented integrative evidence that supports both previously reported and emerging causal proteins, as well as potential drug targets, for asthma.

Methods

Mendelian randomization (MR) analysis, colocalization (COLOC) analysis, phenome-wide association (PWAS) analysis, transcriptome analysis, single-cell data analysis, protein–protein interaction medication targets analysis.

Results

Nephronectin (NPNT) and neuronal growth regulator 1 (NEGR1) were found to be statistically significantly associated with a noticeable protective effect against asthma, tumor necrosis factor, alpha-induced protein 3 (TNFAIP3) showed a suggestive statistical association with a protective effect against asthma in MR analyses. COLOC indicated that NPNT and NEGR1 have greater potential as drug targets. Compared with normal tissues, NPNT exhibited a higher expression level in Type II pneumocytes; NEGR1 was upregulated in smooth muscle cells, regulatory T cells, plasmacytoid dendritic cells, helper T cells; TNFAIP3 expression was decreased in Cluster of differentiation 4 (CD4)-positive alpha-beta T cells, lung ciliated cell 1, smooth muscle cells, whereas it was elevated in CD8-positive alpha-beta T cell 1, helper T cells, and myelocytes in asthma lung tissues. The interaction between Integrin alpha-8 (ITGA8) and NPNT, as well as the interaction between melanocortin-4 receptor and NEGR1, might serve as potential therapeutic targets.

Conclusion

NPNT and NEGR1 could be promising targets for current asthma medications. NEGR1 was first identified in MR of asthma, and we further performed across-omics validation to verify the roles of NPNT, NEGR1, and TNFAIP3.

Zitieren

APA

Yan, Y., & Chen, X. (2026). Proteome-wide Mendelian randomization identifies therapeutic targets for asthma. International Journal of Health Sciences. https://doi.org/10.25259/ijhs_215_2025

Vancouver

Yan Y, Chen X. Proteome-wide Mendelian randomization identifies therapeutic targets for asthma. International Journal of Health Sciences. 2026. doi:10.25259/ijhs_215_2025

BibTeX
@article{Yan2026,
  author = {Yan, Yuhui and Chen, Xiaohua},
  title = {Proteome-wide Mendelian randomization identifies therapeutic targets for asthma},
  journal = {International Journal of Health Sciences},
  year = {2026},
  doi = {10.25259/ijhs_215_2025}
}
Kostenlos starten →